机译:宫颈癌中LNCRNA H19的miR-138-5p的表达降低促进了肿瘤增殖
Zhengzhou Peoples Hosp Dept Gynecol &
Obstet 33 Huanghe Rd Zhengzhou 450003 Henan Peoples R;
Zhengzhou Peoples Hosp Dept Tradit Chinese Med Zhengzhou Henan Peoples R China;
Zhengzhou Peoples Hosp Dept Gynecol &
Obstet 33 Huanghe Rd Zhengzhou 450003 Henan Peoples R;
Zhengzhou Peoples Hosp Dept Gynecol &
Obstet 33 Huanghe Rd Zhengzhou 450003 Henan Peoples R;
Xinxiang Med Univ Affiliated Hosp 1 Dept Gynecol &
Obstet Weihui Peoples R China;
miR-138-5p; Long noncoding RNA (lncRNA) H19; SIRT1; Cervical cancer;
机译:宫颈癌中LNCRNA H19的miR-138-5p的表达降低促进了肿瘤增殖
机译:lncRNA DLG1-AS1通过与miR-107竞争性结合并上调ZHX1在宫颈癌中的表达来促进细胞增殖
机译:LNCRNA气体5的下调通过降低PTEN表达来促进肝癌增殖和耐药性
机译:通过共表达预测LncRNA的癌症关联
机译:类似于2的三方基序(TRIM)的表达促进人类口腔癌的肿瘤生长
机译:lncRNA H19通过竞争性结合miR-200a并抑制大肠癌中β-catenin表达来促进细胞增殖。
机译:LNCRNA TDRG1通过靶向miR-326来调节宫颈癌中MAPK1表达来促进细胞增殖,迁移和侵袭